It is all very easy to make judgement based on hindsight, in which management wouldn't have had, when they had to make the CR call.
And then to lose trust and faith based on what is still unknown, just shows how fickle the market is.
Anyway, was thinking about contracts and manufacturing earlier, if you were a potential buyer of EuGeni, and you're liking the sensitivity/accuracy, but knowing that the saliva trial is coming to an end soon (1-2 weeks IMO), with what is led to believe will come back with positive results.
Do you A) sign a purchasing contract now and "hope" that saliva can be added to CE mark, and potentially be stuck with just a nasal test, or do you B) wait a couple of weeks until CE mark is updated with saliva sampling procedure, then sign a contract?
Could this be the reason why everything is delayed? Manufacturing contracts is waiting on sales contracts, and that is waiting on saliva clinical trials, which is due by June.
ADO Price at posting:
30.0¢ Sentiment: Buy Disclosure: Held
